key: cord-0729021-g21apurq
authors: Eleiwa, Taher; Abdelrahman, Samar N.; ElSheikh, Reem H.; Elhusseiny, Abdelrahman M.
title: Orbital inflammatory disease associated with COVID-19 infection
date: 2021-05-06
journal: J AAPOS
DOI: 10.1016/j.jaapos.2021.04.002
sha: e3164e82e991aa86866ddb84f501ce52cdea9c57
doc_id: 729021
cord_uid: g21apurq

nan

A 10-year-old, previously healthy boy presented to ophthalmology clinic at Benha University for a 5-day history of left progressive periorbital dull-ache swelling. Additionally, he had drooping of his upper eyelid, binocular horizontal diplopia on left gaze, painful eye movement, redness of the eye, low-grade fever, occasional nausea, and vomiting. His mother reported contact 3 week prior to presentation with asymptomatic individuals who were seropositive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The patient denied symptoms of cough, shortness of breath, or general malaise. He was afebrile at presentation (37.5° C).

On examination, best-corrected visual acuity was 20/20 in the right eye and 20/20 in the left eye. No afferent pupillary defect was observed. Intraocular pressure was 14 mm Hg in each eye. There was a moderate left periorbital edema, erythema, mild left ptosis of 2 mm, and a subtle down-in dystopia ( Figure 1A (Table 1) .

Based on the positive RT-PCR test for SARS-CoV-2, home isolation for 2 weeks was advised, and a 5-day oral therapy with azithromycin (AZT) 200 mg/ 5 ml suspension (5 ml once daily) was started. AZT was prescribed for potential bacterial superinfection and for reducing SARS-CoV-2 viral load and spread. 1 For the presumed orbital myositis with the lack of clinical or radiological evidence of infectious orbital cellulitis, oral prednisone (1mg/kg/day) for 2 weeks was prescribed. Dramatic improvement was noticed 2 days after initiating the steroid regimen.

At the 1-month follow-up examination, clinical features and proptosis had resolved completely.

Oral prednisone therapy was tapered by 10 mg weekly. Repeated orbital MRI 14 days after initiation of therapy revealed resolution of the swelling of the left lateral rectus muscle and lacrimal gland.

Although the exact etiology of orbital myositis is unknown, a variety of autoimmune, infective, drug-related, and paraneoplastic conditions have been temporally linked to its pathogenesis. 2 Several autoimmune disorders have been associated with orbital myositis, including granulomatosis with polyangiitis , systemic lupus erythematous, and rheumatoid arthritis. 2 It has also been reported in cysticercosis, herpes zoster ophthalmicus, Whipple disease, and Lyme disease. 2 Several ophthalmic manifestations have been associated with SARS-CoV-2 infection, including dry eye, conjunctival congestion, acute abducens nerve palsy, optic neuropathy, and multiple cranial nerve palsies. [3] [4] [5] Three cases of orbital inflammation in the context of SARS-CoV-2 infection have been reported. 6 In both reports and in our patient, systemic COVID-19 symptoms were either absent or mild. In our patient, there was evidence of lateral rectus myositis, enlarged lacrimal gland, and signs of orbital inflammation. It is unclear whether SARS-CoV-2 infection triggered the orbital inflammation or was coincidental. Immunohistological studies would have been required to discriminate between direct viral infiltration and a sterile immunological process. We speculate that viral particles may have entered to ocular tissues from respiratory droplets, blood spread of the virus via the lacrimal gland, 8 or from the nasopharynx. It is also possible that SARS-CoV-2 infection induced an immunological process targeting orbital tissue. Autoimmune myositis has been reported as a manifestation of COVID-19 infection. 9

PubMed CENTRAL, Google Scholar, and Ovid MEDLINE were searched in February 2021 using the following terms: orbital myositis, orbital cellulitis, orbital pseudotumor, corona virus, and COVID-19 infection.

J o u r n a l P r e -p r o o f 

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study

Orbital myositis: a comprehensive review and reclassification

Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study

Isolated cranial nerve 6 palsy in 6 patients with COVID-19 infection

Acute abducens nerve palsy in a patient with the novel coronavirus disease (COVID-19)

Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19

Acute dacryoadenitis in a patient with SARS-CoV-2 infection

Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report

Myositis as a manifestation of SARS-CoV-2